Open AccessOutcomes of three intravitreal injections of bevacizumab given monthly for diabetic macular oedema is a viable treatment for an economically disadvantaged population
Author(s) -
Aazambir S. Brar,
Vivek B Wani,
Arvind L. Tenagi
Publication year - 2021
Publication title -
african vision and eye health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.186
H-Index - 5
eISSN - 2413-3183
pISSN - 2410-1516
DOI - 10.4102/aveh.v80i1.618
Subject(s) - medicine , bevacizumab , ophthalmology , visual acuity , diabetic retinopathy , endophthalmitis , ranibizumab , population , diabetic macular edema , diabetes mellitus , surgery , chemotherapy , environmental health , endocrinology